Overblog
Edit post Folge diesem Blog Administration + Create my blog
6. Januar 2016 3 06 /01 /Januar /2016 21:16

bangladesh >> published: 18:14 march 23, 2015

Tofail: Bangladesh exports medicines to 107 countries
Tribune Online Report

Commerce Minister Tofail Ahmed has said Bangladesh at present exports medicines to 107 countries, including Germany, USA, France, Italy, UK, Canada, Netherlands and Denmark.

Replying to a question from Hazi Md Salim, an independent lawmaker, of Dhaka-7 constituency,the minister made the disclosure at the Jatiya Sangsad on Monday, reported BSS.

During the question and answer session in the House with Deputy Speaker Fazley Rabbi Mia was in the chair, he said: “The present government has taken various pragmatic steps to turn the growing pharmaceutical sector into a major export earning sector.”

Tofail, in reply to a scripted question of treasury bench member M Abdul Latif from Chittagong 11 constituency, further told the parliament that the export earnings tremendously increased despite the frequent hartal and non-stop shutdown progarmmes enforced by the BNP-led 20-Party alliance since January 6.

According to the last annual report of the Directorate General of Drug Administration (DGDA), 39 Bangladeshi companies exported drugs worth over Tk5.39bn to various countries in the world in 2012.

Even though Bangladesh currently has a Tk90bn pharmaceutical market, 90% of the raw materials have to be imported from abroad.

The local companies are hardly interested in producing raw materials because the cost of producing locally is much higher than the cost of importing them.

At present, only a few companies – Square, Beximco, Ganasastha Pharmaceuticals, Globe and Active Fine – are manufacturing raw materials for drugs like paracetamol, amoxicillin, flucloxacillin, ampicillin and metmorfin, on a limited scale.

Ganashastha Pharmaceuticals Limited (GPL) alone accounts for about 60% of the raw materials manufactured in Bangladesh.

Experts had opined Bangladesh must develop a strong raw materials manufacturing base before 2016; otherwise the rising prices of ingredients in the competitive world market thereafter would adversely affect the industry

- See more at: http://www.dhakatribune.com/bangladesh/2015/mar/23/tofail-bangladesh-exports-medicines-107-countries#sthash.kwcdPtDT.dpuf

bangladesh >> published: 18:14 march 23, 2015

Tofail: Bangladesh exports medicines to 107 countries
Tribune Online Report

Commerce Minister Tofail Ahmed has said Bangladesh at present exports medicines to 107 countries, including Germany, USA, France, Italy, UK, Canada, Netherlands and Denmark.

Replying to a question from Hazi Md Salim, an independent lawmaker, of Dhaka-7 constituency,the minister made the disclosure at the Jatiya Sangsad on Monday, reported BSS.

During the question and answer session in the House with Deputy Speaker Fazley Rabbi Mia was in the chair, he said: “The present government has taken various pragmatic steps to turn the growing pharmaceutical sector into a major export earning sector.”

Tofail, in reply to a scripted question of treasury bench member M Abdul Latif from Chittagong 11 constituency, further told the parliament that the export earnings tremendously increased despite the frequent hartal and non-stop shutdown progarmmes enforced by the BNP-led 20-Party alliance since January 6.

According to the last annual report of the Directorate General of Drug Administration (DGDA), 39 Bangladeshi companies exported drugs worth over Tk5.39bn to various countries in the world in 2012.

Even though Bangladesh currently has a Tk90bn pharmaceutical market, 90% of the raw materials have to be imported from abroad.

The local companies are hardly interested in producing raw materials because the cost of producing locally is much higher than the cost of importing them.

At present, only a few companies – Square, Beximco, Ganasastha Pharmaceuticals, Globe and Active Fine – are manufacturing raw materials for drugs like paracetamol, amoxicillin, flucloxacillin, ampicillin and metmorfin, on a limited scale.

Ganashastha Pharmaceuticals Limited (GPL) alone accounts for about 60% of the raw materials manufactured in Bangladesh.

Experts had opined Bangladesh must develop a strong raw materials manufacturing base before 2016; otherwise the rising prices of ingredients in the competitive world market thereafter would adversely affect the industry

- See more at: http://www.dhakatribune.com/bangladesh/2015/mar/23/tofail-bangladesh-exports-medicines-107-countries#sthash.kwcdPtDT.dpuf

Diesen Post teilen
Repost0
Published by Alamgirkingpin